One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Polycystic Liver and Kidney Disease
Kwabena OwareAdu-GyamfiPraneethKudaravalliJohn Erikson L.Yap
A Small Esophageal Adenoid Cystic Carcinoma Treated by Endoscopic Submucosal Dissection
XiweiDingYingLvShanshanShen
Identifying Care Challenges as Opportunities for Research and Education in Inflammatory Bowel Disease in South Asia
MadhuraBalasubramaniam∗NeilanjanNandi∗TinaAswani-OmprakashShajiSebastianVishalSharma§ParakkalDeepak§
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease
AdjoaAnyane-Yeboa∗aSandraQuezada‡aDavid T.Rubin§SophieBalzora||
AGA Clinical Practice Update on Management of Subepithelial Lesions Encountered During Routine Endoscopy: Expert Review
KavehSharzehi1AmritaSethi2ThomasSavides3
POEM and GERD: Prevalence, Mechanisms, Potential Strategies for Prevention, and Management
KarthikRavi1MohanRamchandani2
Bridging the Gap: Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Population
NikitaChadhaDORichard K.SterlingMD, MSC
Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis
AnneliAndersson∗MattKelly∗KentoImajo‡AtsushiNakajima‡Jonathan A.Fallowfield§GideonHirschfield||MichaelPavlides¶#∗∗Arun J.Sanyal‡‡MazenNoureddin§§RajarshiBanerjee∗AndreaDennis∗StephenHarrison¶
A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease
Jonathan Zhi KaiToh∗aXin-HuiPan∗aPhoebe Wen LinTay∗aCheng HanNg∗Jie NingYong∗JielingXiao∗Jin HeanKoh∗En YingTan‡Eunice Xiang XuanTan∗§||Yock YoungDan∗||¶Poay HuanLoh∗#RogerFoo∗#Nicholas W.S.Chew#Arun J.Sanyal¶Mark D.Muthiah∗§||bMohammad ShadabSiddiqui¶b
International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
Evan S.Dellon1aNirmalaGonsalves2aJ. PabloAbonia3Jeffrey A.Alexander4Nicoleta C.Arva5DanAtkins6Stephen E.Attwood7Marcus K.H.Auth8Dominique D.Bailey91011LucBiederman12CarineBlanchard13Peter A.Bonis14ParomaBose15Albert J.Bredenoord16Joy W.Chang17MirnaChehade18Margaret H.Collins19CarloDi Lorenzo20…Seema S.Aceves84b
Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial
Evan S.Dellon∗Alfredo J.Lucendo‡ChristophSchlag§Alain M.Schoepfer||Gary W.Falk¶GinaEagle#JamesNezamis#Gail M.Comer#KarolKnoop#IkuoHirano∗∗
Development and External Validation of a Model to Predict Complex Treatment After Radiofrequency Ablation for Barrett’s Esophagus With Early Neoplasia
Sanne N.van Munster∗‡EstherNieuwenhuis‡RafBisschops§HildeWillekens§Bas L.A. M.Weusten‡||Lorenza AlvarezHerrero‡AukeBogte||AlaaAlkhalaf¶Ed B.E.Schenk¶Erik J.Schoon#∗∗WouterCurvers#Arjun D.Koch‡‡Pieter Jan F.de Jonge‡‡Tjon J.Tang§§Wouter B.Nagengast||||JessieWesterhof||||Martin H.M. G.Houben¶¶Jacques J.G. H.M.Bergman∗Roos E.Pouw∗
Artificial Intelligence Allows Leaving-In-Situ Colorectal Polyps
CesareHassan12GiuseppinaBalsamo3RobertoLorenzetti4AngeloZullo4GiulioAntonelli456
Image-Enhanced Endoscopy and Molecular Biomarkers Vs Seattle Protocol to Diagnose Dysplasia in Barrett’s Esophagus
MathewVithayathil∗InesModolell‡JacoboOrtiz-Fernandez-Sordo§DahmaneOukrif||ApostolosPappas∗WladyslawJanuszewicz∗¶MariaO’Donovan#AndreasHadjinicolaou∗‡MicheleBianchi∗AdriennBlasko∗JonathanWhite§PhilipKaye∗∗MarcoNovelli||LorenzWernisch‡‡§§KrishRagunath§Massimilianodi Pietro∗‡
Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study
William Y.Park∗aIoannaYiannakou‡§aJulie M.Petersen‖UdoHoffmann¶JiantaoMa#Michelle T.Long∗∗∗
Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort
KentoImajo∗‡HidenoriToyoda§SatoshiYasuda§YasuakiSuzuki‖KatsutoshiSugimoto¶HidekatsuKuroda#TomoyukiAkita∗∗JunkoTanaka∗∗YutakaYasui‡‡NobuharuTamaki‡‡MasayukiKurosaki‡‡NamikiIzumi‡‡AtsushiNakajima∗TakashiKumada§§
Metabolic Dysfunction-Associated Fatty Liver Disease and Subsequent Development of Adverse Pregnancy Outcomes
Seung MiLee∗Young MiJung∗Eun SaemChoi∗Soo HeonKwak‡Ja NamKoo§Ig HwanOh§Byoung JaeKim∗||Sun MinKim∗||Sang YounKim¶Gyoung MinKim#Sae KyungJoo∗∗Bo KyungKoo∗∗SueShin‡‡Errol R.Norwitz§§Chan-WookPark∗Jong KwanJun∗WonKimMD, PhD∗∗bJoong ShinPark∗b
Symptom Classes in Decompensated Liver Disease
LissiHansen∗Michael F.Chang‡ShirinHiatt∗Nathan F.Dieckmann∗ArnabMitra§Karen S.Lyons||Christopher S.Lee||
Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients
AenneHarberts1∗Golda M.Schaub12∗Darius F.Ruether1∗Paul M.Duengelhoef3Thomas T.Brehm12HendrikKarsten1AnahitaFathi1245JacquelineJahnke-Triankowski67LutzFischer67Marylyn M.Addo1245FriedrichHaag3MarcLuetgehetmann28Ansgar W.Lohse12JulianSchulze zur Wiesch12§MartinaSterneck17§
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
IsabelGraupera∗aMajaThiele‡aMiquelSerra-Burriel§bLlorençCaballeria||DominiqueRoulot¶Grace Lai-HungWong#NúriaFabrellas∗∗Indra NeilGuha‡‡AnitaArslanow§§¶¶CarmenExpósito||RosarioHernández||||Guruprasad PadurAithal‡‡Peter R.Galle§§GuillemPera||Vincent Wai-SunWong#FrankLammert¶¶PereGinès∗LaurentCastera##…AleksanderKrag‡b
Immunomodulator Withdrawal From Anti-TNF Therapy Is Not Associated With Loss of Response in Inflammatory Bowel Disease
RemiMahmoud∗aHans-PaulSchultheiss∗aJonasLouwers∗Michielvan der Kaaij∗Borisvan Hellemondt∗NofelMahmmod‡Petravan Boeckel‡BindiaJharap§HermaFidder∗bBasOldenburg∗b
New Therapeutic Strategies Have Changed the Natural History of Pediatric Crohn’s Disease: A Two-Decade Population-Based Study
DelphineLey∗‡ArianeLeroyer‡§ClaireDupont||HélèneSarter‡§ValérieBertrand¶ClaireSpyckerelle#NathalieGuillon§PaulineWils∗∗GuillaumeSavoye‡‡DominiqueTurck∗‡CorinneGower-Rousseau‡§§§MathurinFumery||||Epimad Group
Responsiveness of Magnetic Resonance Enterography Indices for Evaluation of Luminal Disease Activity in Crohn’s Disease
JurijHanžel∗‡§VipulJairath‡||¶ChristopherMa‡#LeonardoGuizzetti‡GuangyongZou‡||∗∗Cynthia S.Santillan‡‡Stuart A.Taylor§§Tanjavan Viegen‡Geert R.D’Haens‡§Brian G.Feagan‡||¶JuliánPanés||||JordiRimola||||
Earlier Anti-TNF Initiation Leads to Long-term Lower Health Care Utilization in Crohn’s Disease but Not in Ulcerative Colitis
Laura E.Targownik∗Charles N.Bernstein‡Eric I.Benchimol§||¶Gilaad G.Kaplan#HarminderSingh‡∗∗AruniTennakoon‡ZoannNugent‡Stephanie B.Coward#M. EllenKuenzig§Sanjay K.Murthy¶‡‡§§
IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus
BénédicteCaron∗Maria T.Abreu‡Corey A.Siegel§RemoPanaccione||Bruce E.Sands¶AxelDignass#DanTurner∗∗IrisDotan‡‡Ailsa L.Hart§§VineetAhuja||||MatthieuAllez¶¶Ashwin N.Ananthakrishnan##SubrataGhosh∗∗∗Anne M.Griffiths‡‡‡JonasHalfvarson§§§ArthurKaser||||||Paulo G.Kotze¶¶¶Ioannis E.Koutroubakis###…LaurentPeyrin-Biroulet∗
Discrete Choice Experiment Reveals Strong Preference for Dietary Treatment Among Patients With Irritable Bowel Syndrome
RoselSturkenboom∗‡DanielKeszthelyi∗Ad A.M.Masclee∗Brigitte A.B.Essers‡
Validation of the Dallas Steatosis Index to Predict Nonalcoholic Fatty Liver Disease in the UK Biobank Population
ScottMcHenry∗YikyungPark‡Nicholas O.Davidson∗
Early Dynamics of MELD Scores Predict Corticosteroid Responsiveness to Severe Acute-Onset Autoimmune Hepatitis
FumieNoguchi∗Po-sungChu∗AyaYoshida∗NobuhitoTaniki∗ReiMorikawa∗YasushiHasegawa‡KarinYamataka∗HitomiHoshi∗RyosukeKasuga∗TakayaTabuchi∗HirotoshiEbinuma∗§MasahiroShinoda‡||HideakiObara‡YukoKitagawa‡TakanoriKanai∗NobuhiroNakamoto∗
Association of Incidental Positron Emission Tomography Uptake in the Esophagus to Gastroesophageal Reflux Disease
Amrit K.KambojSiddharthAgarwalEvelyn F.CarrollJason R.YoungaDavid A.Katzkaa
Patients’ Risk Tolerance for Non-Dietary Therapies in Celiac Disease
DennisDe Leon MorillaMartinVentosoJessicaLebovitsAnneLeeRandiWolfPeter H.R.GreenBenjaminLebwohl
Low Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New Normal
A.ShaukatT.L.MarshS.D.CrockettS.SyngalR.S.BresalierD.E.Brenner
MAFLD and Pregnancy: What are the Consequences?
AkikoNakanishiLindaHenryPhDMindie H.NguyenMD
Deep Remission in Crohn’s Disease: Optional or Quintessential
SuprabhatGiriMBBS, MD, DMSumaswiAngadiMBBS, MD, DNBVaneetJearthMBBS, MD, DM
Some Issues Considered for Clip Closure After Endoscopic Resection of Large Serrated Polyps
QingLuMDXiu-HeLvMDJin-LinYangMD
Comment on Long-Term Risks of Parkinson’s Disease, Surgery, and Colorectal Cancer in Patients with Slow-Transit Constipation
Yen-PoLinMS4Po-KeHsuMDJamesCheng-Chung WeiMD, PhD
Association of Physical Activity to Sarcopenia, Liver Fibrosis, and Cardiovascular Disease: Need a Closer Look!
AnkurJindalMD, DMRakesh K.JagdishMD, DM
Body Mass Index and PNPLA3 Genetic Variant Modify the Association of Alcohol Consumption With Liver Fat Content
ZhenqiuLiuPhDXuehongZhangMD, SCDXingdongChenPhD, MD
Reply
AntonioDe VincentisMDFedericaTavaglioneMDStefanoRomeoMD, PhDUmbertoVespasiani-GentilucciMD, PhD
